NCT03361397

Brief Summary

The primary outcome of this study will be the effect of lidocaine nebulization before LMA insertion on LMA insertion score (within 1 minute of LMA insertion) in adult patients undergoing surgery under general anesthesia. The secondary outcome measures are the effect of LMA insertion on heart rate, arterial blood pressure, SpO2, the first time insertion rate of the LMA, and postoperative complications during LMA removal (soft tissue trauma, coughing, and laryngospasm).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2017

Completed
6 days until next milestone

Study Start

First participant enrolled

November 30, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 4, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2018

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
Last Updated

December 4, 2017

Status Verified

November 1, 2017

Enrollment Period

4 months

First QC Date

November 24, 2017

Last Update Submit

November 28, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • LMA insertion score

    modified three point scale consisting of six variables, which measures the easiness of LMA insertion. Total score Insertion condition 18 Excellent 16-17 Satisfactory \<16 Poor

    within 1 minute of LMA insertion

Secondary Outcomes (2)

  • Heart rate

    1, 3, 5 minutes after LMA insertion

  • Arterial blood pressure

    1, 3, 5 minutes after LMA insertion

Study Arms (2)

Lidocaine nebulization

ACTIVE COMPARATOR

Inhalation of 10 mL nebulized lidocaine hydrochloride via mask nebulizer 5 min before laryngeal mask insertion.

Drug: Lidocaine Hydrochloride

Distilled water nebulization

PLACEBO COMPARATOR

Inhalation of 10 mL of nebulized distilled water solution via mask nebulizer 5 min before laryngeal mask insertion in the preoperative period.

Drug: Distilled Water

Interventions

Lidocaine hydrochloride will be used via mask nebulizer before LMA insertion

Also known as: Xylocaine
Lidocaine nebulization

Distilled Water will be used via mask nebulizer before LMA insertion

Also known as: DW
Distilled water nebulization

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients (Age \>18 yrs)
  • ASA grade 1\&2
  • Scheduled to undergo various elective surgical procedures under general anesthesia using LMA.

You may not qualify if:

  • Patients requiring endotracheal intubation
  • Heavy smokers
  • Grossly obese patients (Body mass index \>35 kg/m2)
  • Patients with suspected difficult airway (Mallampati Grade III or IV)
  • Hypersensitivity to the used drugs
  • Significant cardiovascular
  • Significant pulmonary disease
  • liver disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Gupta A, Kaur S, Attri JP, Saini N. Comparative evaluation of ketamine - propofol, fentanyl - propofol and butorphanol-propofol on haemodynamics and laryngeal mask airway insertion conditions. J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):74-8.

    PMID: 21804711BACKGROUND
  • Williams KA, Barker GL, Harwood RJ, Woodall NM. Combined nebulization and spray-as-you-go topical local anaesthesia of the airway. Br J Anaesth. 2005 Oct;95(4):549-53. doi: 10.1093/bja/aei202. Epub 2005 Aug 26.

    PMID: 16126785BACKGROUND

MeSH Terms

Interventions

Lidocaine

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of anesthesia

Study Record Dates

First Submitted

November 24, 2017

First Posted

December 4, 2017

Study Start

November 30, 2017

Primary Completion

April 2, 2018

Study Completion

April 30, 2018

Last Updated

December 4, 2017

Record last verified: 2017-11